J2 Global Inc. Cmn (JCOM) 65.62 $JCOM j2 Global to

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 9:14 AM

J2 Global Inc. Cmn (JCOM) 65.62 $JCOM

j2 Global to Participate in Two Investor Conferences in June
BusinessWire - Mon Jun 06, 6:00AM CDT
j2 Global, Inc. (NASDAQ:JCOM) today announced its participation in two investor conferences in June 2016. Scott Turicchi, President and Chief Financial Officer of j2 Global will present.
JCOM: 65.62 (-2.52)

j2 Global (JCOM) Q1 Earnings Lag, Sales Top; Dividend Up
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:49AM CDT
j2 Global (JCOM) reported lower-than-expected earnings in the first quarter.
BKFS: 35.12 (-0.67), BOX: 11.24 (-0.58), MTBC: 0.93 (-0.05), JCOM: 65.62 (-2.52)

j2 Global to Participate in Three Investor Conferences in May
BusinessWire - Mon May 09, 6:00AM CDT
j2 Global, Inc. (NASDAQ:JCOM) today announced its participation in three investor conferences in May 2016.
JCOM: 65.62 (-2.52)

j2 Reports First Quarter 2016 Results
BusinessWire - Thu May 05, 3:15PM CDT
--Announces Nineteenth Consecutive Quarterly Dividend Increase
JCOM: 65.62 (-2.52)

j2 Global to Announce First Quarter 2016 Earnings
BusinessWire - Thu Apr 14, 6:00AM CDT
j2 Global, Inc. (Nasdaq:JCOM), the global provider of Internet services and Digital Media, invites the public, members of the press, the financial community, stockholders and other interested parties to listen to a live audio Webcast of its First Quarter Earnings Call at 5 p.m. Eastern Time on Thursday, May 5th, 2016.
JCOM: 65.62 (-2.52)

Daily Esports Show Launches on SiriusXM April 11
BusinessWire - Fri Apr 08, 10:00AM CDT
--Will cover the industry's marquee competitions - League of Legends, Dota2, Counterstrike, Call of Duty and more
JCOM: 65.62 (-2.52), SIRI: 3.92 (-0.06)

Is j2 Global (JCOM) Stock a Solid Choice Right Now?
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 7:58AM CDT
j2 Global (JCOM) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective
JCOM: 65.62 (-2.52)

5 Stocks Brokers Love That Are Great Buys Right Now
Zacks Equity Research - Zacks Investment Research - Thu Mar 17, 12:43PM CDT
The Fed's dovish stance and the statement by the International Energy Agency about falling global oil outputs helped U.S. crude move up almost by 2% and Brent above $40 per barrel.
KMG: 26.53 (+0.04), JCOM: 65.62 (-2.52), SHEN: 33.77 (-0.34), RGR: 57.41 (-2.09), USCR: 64.57 (+0.11)

j2 Global: Citron Report Attacks Business Model, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri Mar 11, 1:35PM CST
j2 Global Inc.'s (JCOM), business model was severely criticized in a research report by Citron Research firm. Also, the firm slashed the company's one-year target price and expects its long-term target price to fall to single-digits.
PCTY: 40.31 (-0.49), RUBI: 14.10 (-0.40), JCOM: 65.62 (-2.52), BNFT: 39.23 (-0.31)

j2 Comments on Its Business and Prospects
BusinessWire - Fri Mar 11, 5:01AM CST
j2 Global, Inc. (NASDAQGS: JCOM). j2 is aware of a report issued yesterday that we believe is both factually incorrect and wrongly critical of j2's businesses and future prospects. We believe j2's historic performance speaks for itself and we have tremendous confidence in our businesses and their prospects.
JCOM: 65.62 (-2.52)

j2 Global Tumbles as Citron Research Goes on Attack
Timothy Green, The Motley Fool - Motley Fool - Thu Mar 10, 3:20PM CST
Image Source: Citron Research What: Shares of cloud services provider j2 Global tumbled on Thursday after Citron Research issued a report that skewered the company and its business model. The stock closed down more than 19%. So what: ...
JCOM: 65.62 (-2.52)

Campaigner(R) Email Marketing Wins Both Gold and Bronze 2016 Stevie(R) Awards for Sales and Customer Service
BusinessWire - Thu Mar 10, 5:02AM CST
j2 Global, Inc. (NASDAQGS: JCOM), a leading provider of business cloud and digital media services, announced today that its Campaigner(R) email marketing solution has won both a Gold and Bronze Stevie(R) Award in the tenth annual Stevie Awards for Sales & Customer Service.
JCOM: 65.62 (-2.52)

j2 Global Reports Record Q4 and Year End 2015 Results and Provides 2016 Outlook
BusinessWire - Wed Feb 10, 3:15PM CST
--Estimates 2016 Revenues between $830M and $860M and 2016 Adjusted Non-GAAP EPS between $4.70 and $5.00
JCOM: 65.62 (-2.52)

j2 Global Communications Has Returned 16.8% Since SmarTrend Recommendation (JCOM)
Comtex SmarTrend(R) - Tue Feb 09, 10:35AM CST
SmarTrend identified a Downtrend for j2 Global Communications (NASDAQ:JCOM) on January 7th, 2016 at $77.68. In approximately 1 month, j2 Global Communications has returned 16.78% as of today's recent price of $64.64.
JCOM: 65.62 (-2.52)

j2 Global to Announce Fourth Quarter and Year End 2015 Earnings
BusinessWire - Tue Jan 19, 6:00AM CST
j2 Global, Inc. (Nasdaq:JCOM), the global provider of Internet services, invites the public, members of the press, the financial community, stockholders and other interested parties to listen to a live audio Webcast of its Fourth Quarter and Year End Earnings Call at 5 p.m. Eastern Time on Wednesday, February 10th 2016.
JCOM: 65.62 (-2.52)

j2 Global(R) Completes Four Acquisitions in Q4 of 2015 - 24 Acquisitions in FY 2015
BusinessWire - Thu Jan 14, 6:00AM CST
j2 Global, Inc. (NASDAQGS: JCOM), the global provider of Internet services, announced today that the Company completed four acquisitions in the fourth quarter of 2015, spanning four business units and three countries.
JCOM: 65.62 (-2.52)

Will j2 Global's Acquisition Spree Boost Business Amid Risks?
Zacks Equity Research - Zacks Investment Research - Thu Dec 31, 10:50AM CST
On Dec 30, 2015, we issued an updated research report on j2 Global Inc. (JCOM).
JCOM: 65.62 (-2.52), CVT: 35.73 (-0.03), KING: 18.00 (unch), HUBS: 49.06 (-0.41)

Look for Shares of j2 Global Communications to Potentially Pullback after Yesterday's 1.55% Rise
Comtex SmarTrend(R) - Mon Dec 28, 4:16PM CST
j2 Global Communications (NASDAQ:JCOM) traded in a range yesterday that spanned from a low of $80.50 to a high of $82.50. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $81.57 on volume of 470,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JCOM: 65.62 (-2.52)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ortho Molecular and HANS: Streamlining Functional Medicine

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

CURE Intl and Thoughtworks Step Into Digital Era

Pushing Paper Out, Digitizing In In a world where tech is king, why were hospitals—crucial, life-saving institutions—still bogged down by dusty folders and ink smudges? Well, not anymore for CURE International, not with Thoughtworks stepping up to the plate. This ain't just swapping paper for pixels; it's a lifeline for kids getting world-class surgical care without...

Jinko Solar Joins B20 Summit: Energy Forefront Focus

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Jubilant Eyes MPN Breakthrough with JBI-802 Data at ASH

Presenting the Case for JBI-802 From the bustling circus of drug development, here comes Jubilant Therapeutics, strutting their stuff with JBI-802, a dual inhibitor designed to tackle myeloproliferative neoplasms (MPNs) with a one-two punch. Now, they're set to drop some spicy deets at the 68th ASH Annual Meeting in New Orleans this December. So what's the fuss about?...

Agilyx's Q3 Update: GreenDot Shines Amid Mixed Results

Peeking into Agilyx's Financial Odyssey Just as I sip my morning coffee pondering the highs and lows of the market, here comes Agilyx ASA splashing some liquidity on the scene. The Q3 report paints the company in various shades—from solid greens to hesitant reds. Nothing like the thrill of untangling mixed results over a quiet day, huh? GreenDot's Climb to Profitability...

Inflatable Wonders Turn Christmas into a Hoot at Lowe's

Inflatables Bringing the Cheer (and Laughs) Well, it's that season again—where decorations either have us grumbling at the electric bill or chuckling at the lawn art. Lowe's has teamed up with Gemmy to serve a heaping platter of holiday giggles this year. They've rolled out a quirky lineup of inflatables that go from shivering Highland cows to dinosaurs and elves....

LG Innotek Scores Hat Trick with CES Innovation Wins

LG Innotek's Lighting Triumph Here we go again, LG Innotek just snagged their third CES Innovation Award in a row, this time for their cutting-edge vehicle lighting module, Nexlide C+. It's one for the books—breaking into the 2027 CES spotlight with innovative tech that not only grabs the eyes but could also steal the hearts of investors willing to bet on the future of...

RF MEDICAL Expands into Europe with New CE Certification

RF MEDICAL Secures CE Marking for Mi-BLATOR™ Just when you think the European medical device market's hit its saturation point, RF MEDICAL decides to kick the door open with their Mi-BLATOR™ microwave ablation system. This ain't just another plastic gadget, folks; it's got that shiny new CE marking under the European Union's Medical Device Regulation (MDR). Now, what...

BD Sets Stage for Investor Day in December 2026

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Centrus Energy Welcomes Nuclear Veteran to Leadership

Navigating a New Era at Centrus When you hear about seasoned veterans stepping up to the plate in the energy sector, it's time to perk up your ears. Centrus Energy (NYSE:LEU), a big player in nuclear fuel, just added Kevin Graney to their Board of Directors. This isn't your run-of-the-mill appointment; it packs nearly three decades of nuclear tech and national security...